[{"quiz_id": "20251225T204141396Z_grok-4-0709_seed132", "question_id": "20251225T204141396Z_grok-4-0709_seed132-001", "question": "A 45-year-old man presents with progressive bilateral leg weakness, urinary incontinence, and episodic vertigo over 6 months. Examination reveals spastic paraparesis, upbeat nystagmus, and a positive Romberg sign. MRI shows T2 hyperintensities in the cerebellar peduncles and periventricular white matter. CSF analysis is normal except for elevated IgG index. What is the most likely diagnosis?", "options": ["Primary progressive multiple sclerosis", "Susac syndrome", "Behçet disease", "Neuromyelitis optica spectrum disorder", "Cerebrotendinous xanthomatosis"], "answer": "B", "answer_index": 1, "explanation": "Susac syndrome is characterized by the triad of encephalopathy, branch retinal artery occlusions, and sensorineural hearing loss, but can present with cerebellar involvement and white matter lesions mimicking multiple sclerosis. Primary progressive multiple sclerosis typically lacks the specific upbeat nystagmus and vertigo seen here, while Behçet disease often includes oral ulcers and uveitis, which are absent. Neuromyelitis optica spectrum disorder usually features optic neuritis or transverse myelitis with aquaporin-4 antibodies, not present in this case.", "generator_model": "grok-4-0709", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurology", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: M (primary; secondary U). Verdict on keyed answer: Not uniquely determinable. Key stem clues include progressive spastic paraparesis, urinary incontinence, episodic vertigo, upbeat nystagmus, positive Romberg sign, T2 hyperintensities in cerebellar peduncles and periventricular white matter, and elevated CSF IgG index—these suggest a demyelinating or inflammatory process but do not specify auditory or retinal involvement. Main logical issue(s): The vignette is underspecified, lacking critical details like hearing loss, retinal artery occlusions, or encephalopathy to definitively support Susac syndrome (B) over primary progressive multiple sclerosis (A); both are defensible as best answers given the overlap in white matter lesions, cerebellar involvement, and CSF findings, while alternatives (C: lacks ulcers/uveitis; D: lacks optic neuritis/AQP4; E: lacks xanthomas/cataracts) are weaker but not fully excluded without more data. Main medical accuracy issue(s): The rationale inaccurately claims primary progressive MS typically lacks upbeat nystagmus and vertigo, which contradicts standard knowledge as MS commonly features cerebellar/brainstem symptoms; elevated IgG index strongly favors MS, and Susac often presents with incomplete triad but requires supportive findings not provided here. Minimal fix: Add 'normal audiometry and fundoscopy' to the stem to exclude Susac and uniquely support A as the key.\",\n  \"medical_accuracy_score\": 2,\n  \"logical_validity\": false,\n  \"logical_false_reason\": \"M\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (primary; secondary U). Verdict on keyed answer: Not uniquely determinable. Key stem clues include progressive spastic paraparesis, urinary incontinence, episodic vertigo, upbeat nystagmus, positive Romberg sign, T2 hyperintensities in cerebellar peduncles and periventricular white matter, and elevated CSF IgG index—these suggest a demyelinating or inflammatory process but do not specify auditory or retinal involvement. Main logical issue(s): The vignette is underspecified, lacking critical details like hearing loss, retinal artery occlusions, or encephalopathy to definitively support Susac syndrome (B) over primary progressive multiple sclerosis (A); both are defensible as best answers given the overlap in white matter lesions, cerebellar involvement, and CSF findings, while alternatives (C: lacks ulcers/uveitis; D: lacks optic neuritis/AQP4; E: lacks xanthomas/cataracts) are weaker but not fully excluded without more data. Main medical accuracy issue(s): The rationale inaccurately claims primary progressive MS typically lacks upbeat nystagmus and vertigo, which contradicts standard knowledge as MS commonly features cerebellar/brainstem symptoms; elevated IgG index strongly favors MS, and Susac often presents with incomplete triad but requires supportive findings not provided here. Minimal fix: Add 'normal audiometry and fundoscopy' to the stem to exclude Susac and uniquely support A as the key.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251225T204141396Z_grok-4-0709_seed132", "question_id": "20251225T204141396Z_grok-4-0709_seed132-002", "question": "A 32-year-old woman with a history of atopic dermatitis develops widespread pruritic vesicles and bullae after starting a new biologic therapy. Biopsy shows subepidermal clefting with eosinophils and flame figures. Direct immunofluorescence is negative. What is the most appropriate next step in management?", "options": ["Switch to dupilumab", "Initiate dapsone therapy", "Administer rituximab", "Prescribe high-dose systemic corticosteroids", "Perform patch testing for contact allergens"], "answer": "B", "answer_index": 1, "explanation": "This presentation suggests bullous pemphigoid-like eruption induced by biologic therapy, but the flame figures and eosinophilic spongiosis point to eosinophilic cellulitis (Wells syndrome), which responds well to dapsone. Switching to dupilumab might exacerbate atopic conditions without addressing the eosinophilic component, while rituximab is reserved for refractory autoimmune bullous diseases. Systemic corticosteroids could provide temporary relief but are not first-line for this entity.", "generator_model": "grok-4-0709", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Dermatology", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K. Verdict on keyed answer: Miskeyed. Key stem clues: 32-year-old woman with atopic dermatitis develops widespread pruritic vesicles and bullae after new biologic therapy; biopsy reveals subepidermal clefting with eosinophils and flame figures; direct immunofluorescence negative. These findings strongly suggest Wells syndrome (eosinophilic cellulitis), a drug-induced eosinophilic dermatosis characterized by flame figures and possible bullous lesions, with negative DIF ruling out autoimmune bullous diseases like pemphigoid. Main logical issue: While the stem supports a unique best answer among options (D, high-dose systemic corticosteroids as first-line treatment per standard guidelines), the provided key (B, dapsone) mismatches it, as dapsone is not first-line but used adjunctively or for refractory cases. Main medical accuracy issue: The rationale inaccurately claims systemic corticosteroids are not first-line for this entity and provide only temporary relief, contradicting mainstream dermatological consensus (e.g., UpToDate, major texts) where glucocorticoids are the mainstay; it also references 'eosinophilic spongiosis' absent from the stem, introducing extraneous details. Minimal fix: Change the keyed answer to D and revise the rationale to reflect accurate treatment hierarchy for Wells syndrome, emphasizing steroids as initial management.\",\n  \"medical_accuracy_score\": 2,\n  \"logical_validity\": false,\n  \"logical_false_reason\": \"K\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K. Verdict on keyed answer: Miskeyed. Key stem clues: 32-year-old woman with atopic dermatitis develops widespread pruritic vesicles and bullae after new biologic therapy; biopsy reveals subepidermal clefting with eosinophils and flame figures; direct immunofluorescence negative. These findings strongly suggest Wells syndrome (eosinophilic cellulitis), a drug-induced eosinophilic dermatosis characterized by flame figures and possible bullous lesions, with negative DIF ruling out autoimmune bullous diseases like pemphigoid. Main logical issue: While the stem supports a unique best answer among options (D, high-dose systemic corticosteroids as first-line treatment per standard guidelines), the provided key (B, dapsone) mismatches it, as dapsone is not first-line but used adjunctively or for refractory cases. Main medical accuracy issue: The rationale inaccurately claims systemic corticosteroids are not first-line for this entity and provide only temporary relief, contradicting mainstream dermatological consensus (e.g., UpToDate, major texts) where glucocorticoids are the mainstay; it also references 'eosinophilic spongiosis' absent from the stem, introducing extraneous details. Minimal fix: Change the keyed answer to D and revise the rationale to reflect accurate treatment hierarchy for Wells syndrome, emphasizing steroids as initial management.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251225T204141396Z_grok-4-0709_seed132", "question_id": "20251225T204141396Z_grok-4-0709_seed132-003", "question": "A 58-year-old man with incomplete tetraplegia from a C5 spinal cord injury undergoes functional electrical stimulation therapy. After 3 months, he develops shoulder pain and limited abduction. Imaging reveals heterotopic ossification around the glenohumeral joint. What is the most effective intervention to preserve joint mobility?", "options": ["Bisphosphonate therapy", "Low-dose radiation", "Surgical excision", "Indomethacin prophylaxis", "Passive range-of-motion exercises"], "answer": "B", "answer_index": 1, "explanation": "Low-dose radiation therapy is highly effective in preventing maturation of heterotopic ossification in spinal cord injury patients, preserving joint function without systemic side effects. Bisphosphonates like etidronate can inhibit mineralization but are less targeted and may cause gastrointestinal issues. Surgical excision is considered only after ossification matures and if function is severely impaired, not as a primary intervention.", "generator_model": "grok-4-0709", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Physical Medicine and Rehabilitation", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include C5 spinal cord injury with incomplete tetraplegia, functional electrical stimulation therapy, development of shoulder pain and limited abduction after 3 months, and imaging confirming heterotopic ossification (HO) around the glenohumeral joint, implying early-stage HO requiring intervention to preserve mobility. These clues point to preventing HO maturation as the priority, making low-dose radiation (B) the most effective, targeted option per standard care. Main logical issue(s): None; the stem provides sufficient details for discriminating a single best answer without contradictions or underspecification, as options are distinct interventions with clear hierarchies in efficacy for this scenario. Main medical accuracy issue(s): None; the keyed answer aligns with current guidelines (e.g., radiation therapy inhibits HO progression in SCI patients with minimal side effects, superior to bisphosphonates' systemic risks or indomethacin's prophylactic role; surgery is reserved for mature HO). The item's logic is sound, reflecting realistic associations between SCI, FES, and HO risk. Minimal fix: No edit needed; the item is already unambiguous and accurate, though adding 'early-stage' to HO description could enhance precision without altering intent.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include C5 spinal cord injury with incomplete tetraplegia, functional electrical stimulation therapy, development of shoulder pain and limited abduction after 3 months, and imaging confirming heterotopic ossification (HO) around the glenohumeral joint, implying early-stage HO requiring intervention to preserve mobility. These clues point to preventing HO maturation as the priority, making low-dose radiation (B) the most effective, targeted option per standard care. Main logical issue(s): None; the stem provides sufficient details for discriminating a single best answer without contradictions or underspecification, as options are distinct interventions with clear hierarchies in efficacy for this scenario. Main medical accuracy issue(s): None; the keyed answer aligns with current guidelines (e.g., radiation therapy inhibits HO progression in SCI patients with minimal side effects, superior to bisphosphonates' systemic risks or indomethacin's prophylactic role; surgery is reserved for mature HO). The item's logic is sound, reflecting realistic associations between SCI, FES, and HO risk. Minimal fix: No edit needed; the item is already unambiguous and accurate, though adding 'early-stage' to HO description could enhance precision without altering intent.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251225T204141396Z_grok-4-0709_seed132", "question_id": "20251225T204141396Z_grok-4-0709_seed132-004", "question": "A 67-year-old woman with a history of migraine presents with acute onset of hemianopia, ataxia, and confusion. CT angiography shows occlusion of the posterior inferior cerebellar artery with extension into the basilar artery. Despite thrombolysis, she deteriorates with locked-in syndrome. What rare complication is most likely responsible for this progression?", "options": ["Reperfusion injury", "Basilar artery dissection", "Paradoxical embolism", "Top-of-the-basilar syndrome", "Intracranial atherosclerotic disease"], "answer": "C", "answer_index": 2, "explanation": "Paradoxical embolism through a patent foramen ovale can cause extension of infarction in vertebrobasilar territory, leading to locked-in syndrome despite initial thrombolysis. Reperfusion injury typically manifests as hemorrhage, not progression of ischemia, while basilar artery dissection would show characteristic imaging findings not described. Top-of-the-basilar syndrome involves thalamic and midbrain infarction but lacks the cerebellar involvement here.", "generator_model": "grok-4-0709", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurology", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: U\\nVerdict on keyed answer: Not uniquely determinable\\nKey stem clues that drive (or fail to drive) a unique best answer: Migraine history (potential hint at PFO), acute hemianopia, ataxia, confusion suggesting vertebrobasilar ischemia, CTA showing PICA occlusion extending to basilar artery, deterioration to locked-in syndrome despite thrombolysis. These clues point to progression of ischemia, but lack specific evidence (e.g., PFO, shunt, or DVT) to uniquely favor paradoxical embolism over other potential causes like dissection propagation or re-thrombosis from atherosclerosis.\\nMain logical issue(s), if any: Underspecified (U); the stem misses critical details like cardiac evaluation or shunt confirmation needed to definitively select paradoxical embolism as the rare complication causing progression. This requires unstated assumption of PFO based solely on migraine history, allowing alternatives like B (dissection) or E (atherosclerosis) to remain plausible without explicit ruling out.\\nMain medical accuracy issue(s), if any: Mostly accurate; paradoxical embolism via PFO can cause extending vertebrobasilar infarcts leading to locked-in syndrome, consistent with guidelines. However, rationale overstates by assuming PFO without stem support, and top-of-the-basilar exclusion is reasonable but stem's cerebellar involvement fits variably. No major errors, but nuance missing on diagnostic confirmation.\\nMinimal fix: Add to stem: 'Transesophageal echocardiogram reveals a patent foramen ovale with right-to-left shunt.' This provides the missing detail to uniquely support C.\",\n  \"medical_accuracy_score\": 3,\n  \"logical_validity\": false,\n  \"logical_false_reason\": \"U\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U\nVerdict on keyed answer: Not uniquely determinable\nKey stem clues that drive (or fail to drive) a unique best answer: Migraine history (potential hint at PFO), acute hemianopia, ataxia, confusion suggesting vertebrobasilar ischemia, CTA showing PICA occlusion extending to basilar artery, deterioration to locked-in syndrome despite thrombolysis. These clues point to progression of ischemia, but lack specific evidence (e.g., PFO, shunt, or DVT) to uniquely favor paradoxical embolism over other potential causes like dissection propagation or re-thrombosis from atherosclerosis.\nMain logical issue(s), if any: Underspecified (U); the stem misses critical details like cardiac evaluation or shunt confirmation needed to definitively select paradoxical embolism as the rare complication causing progression. This requires unstated assumption of PFO based solely on migraine history, allowing alternatives like B (dissection) or E (atherosclerosis) to remain plausible without explicit ruling out.\nMain medical accuracy issue(s), if any: Mostly accurate; paradoxical embolism via PFO can cause extending vertebrobasilar infarcts leading to locked-in syndrome, consistent with guidelines. However, rationale overstates by assuming PFO without stem support, and top-of-the-basilar exclusion is reasonable but stem's cerebellar involvement fits variably. No major errors, but nuance missing on diagnostic confirmation.\nMinimal fix: Add to stem: 'Transesophageal echocardiogram reveals a patent foramen ovale with right-to-left shunt.' This provides the missing detail to uniquely support C.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251225T204141396Z_grok-4-0709_seed132", "question_id": "20251225T204141396Z_grok-4-0709_seed132-005", "question": "A 28-year-old man presents with erythematous plaques on the trunk and extremities that worsen with sun exposure. Biopsy reveals interface dermatitis with vacuolar degeneration and apoptotic keratinocytes. Serology shows positive anti-Ro/SSA antibodies. Despite hydroxychloroquine, lesions persist. What is the most appropriate adjunctive therapy?", "options": ["Thalidomide", "Mycophenolate mofetil", "Intravenous immunoglobulin", "Lenalidomide", "Apremilast"], "answer": "A", "answer_index": 0, "explanation": "This is subacute cutaneous lupus erythematosus, and thalidomide is effective for refractory cases with photosensitivity and anti-Ro positivity due to its anti-angiogenic and immunomodulatory effects. Mycophenolate mofetil is more suited for systemic lupus but less effective for cutaneous-limited disease. Intravenous immunoglobulin is reserved for severe systemic involvement, not primarily cutaneous manifestations.", "generator_model": "grok-4-0709", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Dermatology", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include erythematous plaques on trunk/extremities worsening with sun exposure, biopsy showing interface dermatitis with vacuolar degeneration and apoptotic keratinocytes, positive anti-Ro/SSA antibodies, and persistence despite hydroxychloroquine, collectively pointing to refractory subacute cutaneous lupus erythematosus (SCLE). These findings support thalidomide as the most appropriate adjunctive therapy due to its efficacy in photosensitive, anti-Ro-positive refractory cutaneous lupus via anti-angiogenic and immunomodulatory effects. Main logical issue(s): none; the stem provides sufficient discriminating details to identify a single best answer without contradictions or underspecification, and options allow clear discrimination. Main medical accuracy issue(s): none; the keyed answer aligns with current mainstream standards for managing refractory SCLE, where thalidomide is a recognized second-line option after antimalarials, consistent with dermatology guidelines and literature (e.g., its use in anti-Ro-associated cases). Alternatives are appropriately inferior: mycophenolate better for systemic lupus, IVIG for severe systemic involvement, lenalidomide lacks strong evidence in SCLE, and apremilast is not standard for lupus. Minimal fix: none needed; item is unambiguous and accurate as written.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include erythematous plaques on trunk/extremities worsening with sun exposure, biopsy showing interface dermatitis with vacuolar degeneration and apoptotic keratinocytes, positive anti-Ro/SSA antibodies, and persistence despite hydroxychloroquine, collectively pointing to refractory subacute cutaneous lupus erythematosus (SCLE). These findings support thalidomide as the most appropriate adjunctive therapy due to its efficacy in photosensitive, anti-Ro-positive refractory cutaneous lupus via anti-angiogenic and immunomodulatory effects. Main logical issue(s): none; the stem provides sufficient discriminating details to identify a single best answer without contradictions or underspecification, and options allow clear discrimination. Main medical accuracy issue(s): none; the keyed answer aligns with current mainstream standards for managing refractory SCLE, where thalidomide is a recognized second-line option after antimalarials, consistent with dermatology guidelines and literature (e.g., its use in anti-Ro-associated cases). Alternatives are appropriately inferior: mycophenolate better for systemic lupus, IVIG for severe systemic involvement, lenalidomide lacks strong evidence in SCLE, and apremilast is not standard for lupus. Minimal fix: none needed; item is unambiguous and accurate as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251225T204141396Z_grok-4-0709_seed132", "question_id": "20251225T204141396Z_grok-4-0709_seed132-006", "question": "A 42-year-old woman with rheumatoid arthritis and secondary fibromyalgia undergoes multidisciplinary pain management. She reports persistent widespread pain despite optimized pharmacotherapy. Quantitative sensory testing shows central sensitization. What advanced rehabilitation technique is most likely to provide long-term benefit?", "options": ["Graded motor imagery", "Transcutaneous electrical nerve stimulation", "Aquatic therapy", "Cognitive behavioral therapy alone", "Spinal cord stimulation"], "answer": "A", "answer_index": 0, "explanation": "Graded motor imagery effectively addresses central sensitization in fibromyalgia by reprogramming cortical representations, leading to sustained pain reduction in rheumatoid arthritis overlap. Transcutaneous electrical nerve stimulation provides short-term relief but does not target central mechanisms. Spinal cord stimulation is invasive and indicated for neuropathic pain, not widespread fibromyalgia pain.", "generator_model": "grok-4-0709", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Physical Medicine and Rehabilitation", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues that drive a unique best answer: 42-year-old woman with rheumatoid arthritis and secondary fibromyalgia, persistent widespread pain despite optimized pharmacotherapy, quantitative sensory testing confirming central sensitization; question seeks advanced rehabilitation technique for long-term benefit. These clues emphasize central mechanisms in fibromyalgia overlap, pointing to interventions targeting cortical reprogramming over short-term or invasive options.\\nMain logical issue(s), if any: None; the stem provides sufficient discriminating details (central sensitization, long-term focus) to support graded motor imagery as uniquely best, with alternatives inferior based on mechanism, duration, or invasiveness.\\nMain medical accuracy issue(s), if any: Item aligns with current evidence; graded motor imagery is supported for central sensitization in fibromyalgia (e.g., via mirror therapy and mental practice to alter cortical maps), per guidelines like those from pain societies. Rationale accurately notes limitations of TENS (short-term peripheral relief) and SCS (for refractory neuropathic pain, not widespread sensitization). CBT is evidence-based but 'alone' distinguishes it from comprehensive rehab; no major inaccuracies or outdated elements.\\nMinimal fix: No fix required; item is already unambiguous and accurate, though adding 'non-pharmacologic' to stem could further emphasize rehab focus if desired.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues that drive a unique best answer: 42-year-old woman with rheumatoid arthritis and secondary fibromyalgia, persistent widespread pain despite optimized pharmacotherapy, quantitative sensory testing confirming central sensitization; question seeks advanced rehabilitation technique for long-term benefit. These clues emphasize central mechanisms in fibromyalgia overlap, pointing to interventions targeting cortical reprogramming over short-term or invasive options.\nMain logical issue(s), if any: None; the stem provides sufficient discriminating details (central sensitization, long-term focus) to support graded motor imagery as uniquely best, with alternatives inferior based on mechanism, duration, or invasiveness.\nMain medical accuracy issue(s), if any: Item aligns with current evidence; graded motor imagery is supported for central sensitization in fibromyalgia (e.g., via mirror therapy and mental practice to alter cortical maps), per guidelines like those from pain societies. Rationale accurately notes limitations of TENS (short-term peripheral relief) and SCS (for refractory neuropathic pain, not widespread sensitization). CBT is evidence-based but 'alone' distinguishes it from comprehensive rehab; no major inaccuracies or outdated elements.\nMinimal fix: No fix required; item is already unambiguous and accurate, though adding 'non-pharmacologic' to stem could further emphasize rehab focus if desired.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]